Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compound Realgar-Indigo Naturalis + Imatinib in Ph+ CML-CP
NCT01755325Phase 3Suspended
- Start
- Nov 2012
- Primary completion
- Dec 2018
- Modality
- Small Molecules, Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of Compound Huangdai Tablet in chronic myeloid leukemia (CML). Started Nov 2012; status: suspended.
02
Drugs
Compound Huangdai Tablet
03
Conditions
chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT01755325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01755325.